Ali Behbahani

Insider profile

Currently holds positions in CRISPR Therapeutics AG, Genocea Biosciences Inc and Adaptimmune Therapeutics PLC

Performance

Overall performance
1.6
Performance over holding periods
1.6
30 days 90 days 120 days
Average return -18% 8.2% 15.1%
Success rate 26% 68% 82%
Transactions
4 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director CRISPR Therapeutics AG April 1, 2015 -
Independent Director Genocea Biosciences Inc Feb. 8, 2018 -
Non-Executive Independent Director Adaptimmune Therapeutics PLC Sept. 1, 2014 -
Independent Director Nevro Corp Sept. 1, 2014 - March 19, 2019
Ali Behbahani's trades of CRISPR Therapeutics AG's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
229.19
Quantity 52,426 +23.1%
Value US$493,526
Transaction date
Proposed sale
Price
107.34
Quantity 208
Value US$1,159,463
Transaction date
Purchase
Price
230.62
Quantity 11,416 +27.1%
Value US$3,961,577
US CVRx Inc (CVRX)
Transaction date
Proposed sale
Price
15.30
Quantity 21,837
Value US$334,106
US CVRx Inc (CVRX)
Transaction date
Proposed sale
Price
14.07
Quantity 9
Value US$127
Transaction date
Purchase
Price
16.00
Quantity 500,000 +16.1%
Value US$8,000,000
US Savara Inc (SVRA)
Transaction date
Purchase
Price
3.00
Quantity 333,333 +1.4%
Value US$999,999
Transaction date
Purchase
Price
1.90
Quantity 948,948 New position
Value US$1,803,001
Transaction date
Purchase
Price
1.90
Quantity 2,631,578 +33.8%
Value US$4,999,998
Transaction date
Purchase
Price
1.75
Quantity 5,714,285 +114.3%
Value US$9,999,999
Transaction date
Purchase
Price
13.00
Quantity 769,230 +33.6%
Value US$9,999,990
Transaction date
Purchase
Price
2.25
Quantity 3,151,260 +43.6%
Value US$7,090,335
US Akouos Inc (AKUS)
Transaction date
Purchase
Price
17.00
Quantity 588,235 +15.9%
Value US$9,999,995
Transaction date
Purchase
Price
3.50
Quantity 2,857,142 +65.4%
Value US$9,999,997
Transaction date
Purchase
Price
10.00
Quantity 1,500,000 +51.0%
Value US$15,000,000
Transaction date
Purchase
Price
10.00
Quantity 1,000,000 +51.6%
Value US$10,000,000
Transaction date
Purchase
Price
0.47
Quantity 9,948,269 +39.8%
Value US$4,688,619
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-21 2026-09-17
S Sale
52,426 +23.1%
229.19
US$493,526 		52,426 +23.1% 229.19 US$493,526
2026-09-17 2026-09-17
PrS Proposed sale
208
107.34
US$1,159,463 		208 107.34 US$1,159,463
2026-02-11 2026-02-09
B Purchase
11,416 +27.1%
230.62
US$3,961,577 		11,416 +27.1% 230.62 US$3,961,577
2025-10-06 2025-10-02
S Sale
900 -0.0%
6.75
US$6,075 		900 -0.0% 6.75 US$6,075
2025-10-06 2025-10-02
S Sale
2,455 -0.1%
6.75
US$16,571 		2,455 -0.1% 6.75 US$16,571
2025-10-06 2025-10-02
S Sale
280 -0.1%
6.75
US$1,890 		280 -0.1% 6.75 US$1,890
2025-10-06 2025-10-02
S Sale
280 -0.0%
6.75
US$1,890 		280 -0.0% 6.75 US$1,890
2025-08-19 2025-08-18
S Sale
14,671,794 -100.0%
0.01
US$176,062 		14,671,794 -100.0% 0.01 US$176,062
2025-08-19 2025-08-15
S Sale
4,828,206 -24.8%
0.01
US$53,110 		4,828,206 -24.8% 0.01 US$53,110
2024-11-29 2024-11-29
US CVRx Inc (CVRX)
PrS Proposed sale
21,837
15.30
US$334,106 		21,837 15.30 US$334,106
2024-11-18 2024-11-18
US CVRx Inc (CVRX)
PrS Proposed sale
9
14.07
US$127 		9 14.07 US$127
2024-09-17 2024-09-16
B Purchase
500,000 +16.1%
16.00
US$8,000,000 		500,000 +16.1% 16.00 US$8,000,000
2023-07-19 2023-07-17
US Savara Inc (SVRA)
B Purchase
333,333 +1.4%
3.00
US$999,999 		333,333 +1.4% 3.00 US$999,999
2023-07-06 2023-07-05
B Purchase
1,000,000 +29.0%
5.00
US$5,000,000 		1,000,000 +29.0% 5.00 US$5,000,000
2022-05-26 2022-05-25
S Sale
4,445,093 -100.0%
0.08
US$362,720 		4,445,093 -100.0% 0.08 US$362,720
2022-05-26 2022-05-24
S Sale
5,931,843 -57.2%
0.07
US$387,943 		5,931,843 -57.2% 0.07 US$387,943
2022-04-13 2022-04-11
B Purchase
948,948 New position
1.90
US$1,803,001 		948,948 New position 1.90 US$1,803,001
2022-04-13 2022-04-11
B Purchase
2,631,578 +33.8%
1.90
US$4,999,998 		2,631,578 +33.8% 1.90 US$4,999,998
2021-10-19 2021-10-18
B Purchase
1,851,852
0.00
US$0 		1,851,852 0.00 US$0
2021-03-18 2021-03-16
B Purchase
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2020-12-07 2020-12-04
B Purchase
4,398,602 +214.3%
0.62
US$2,735,930 		4,398,602 +214.3% 0.62 US$2,735,930
2020-09-22 2020-09-18
B Purchase
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-07-28 2020-07-24
B Purchase
3,151,260 +43.6%
2.25
US$7,090,335 		3,151,260 +43.6% 2.25 US$7,090,335
2020-07-01 2020-06-30
US Akouos Inc (AKUS)
B Purchase
588,235 +15.9%
17.00
US$9,999,995 		588,235 +15.9% 17.00 US$9,999,995
2020-04-13 2020-04-03
S Sale
564 -0.0%
2.66
US$1,500 		564 -0.0% 2.66 US$1,500
2020-02-05 2020-02-03
B Purchase
800,000 +30.2%
19.00
US$15,200,000 		800,000 +30.2% 19.00 US$15,200,000
2020-01-28 2020-01-24
B Purchase
7,500,000 +62.5%
0.67
US$5,000,250 		7,500,000 +62.5% 0.67 US$5,000,250
2019-07-24 2019-07-22
B Purchase
450,000 +12.0%
15.00
US$6,750,000 		450,000 +12.0% 15.00 US$6,750,000
2019-06-25 2019-06-24
B Purchase
2,857,142 +65.4%
3.50
US$9,999,997 		2,857,142 +65.4% 3.50 US$9,999,997
2019-05-13 2019-05-09
B Purchase
1,500,000 +51.0%
10.00
US$15,000,000 		1,500,000 +51.0% 10.00 US$15,000,000
2019-05-13 2019-05-09
B Purchase
1,000,000 +51.6%
10.00
US$10,000,000 		1,000,000 +51.6% 10.00 US$10,000,000
2019-05-09 2019-05-07
B Purchase
1,136,704 +124.1%
1.08
US$1,227,640 		1,136,704 +124.1% 1.08 US$1,227,640
2019-02-19 2019-02-14
B Purchase
9,948,269 +39.8%
0.47
US$4,688,619 		9,948,269 +39.8% 0.47 US$4,688,619